Ziccum CEO Göran Conradson tours Swedish investors: ‘powders, not liquids the future for biologic therapies’
“Biologics are one of the fastest-growing therapies in the world, yet 80% are still formulated as liquids—so they’re extremely costly to transport. We have a solution”, Ziccum CEO Göran Conradson is presenting to investors in Stockholm, Gothenburg and Malmö on the Ziccum investment case: formulating vaccines and biologics from liquids to powders.Göran Conradson, CEO for Ziccum AB, is a man on a mission: To formulate biologic therapies, including vaccines, proteins and antibodies, as powders not liquids. Making them more resilient and cost-effective to transport, and enabling Ziccum’s